In chronic lymphocytic leukemia (CLL), the presence of a complex karyotype, as defined by ≥3 chromosomal abnormalities in the neoplastic clone, has been shown to confer an adverse prognosis in retrospective series of untreated patients and in patients treated with chemoimmunotherapy
Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study
Albano F.;
2021-01-01
Abstract
In chronic lymphocytic leukemia (CLL), the presence of a complex karyotype, as defined by ≥3 chromosomal abnormalities in the neoplastic clone, has been shown to confer an adverse prognosis in retrospective series of untreated patients and in patients treated with chemoimmunotherapyFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab.pdf
accesso aperto
Descrizione: articolo principale
Tipologia:
Documento in Versione Editoriale
Licenza:
Creative commons
Dimensione
673.11 kB
Formato
Adobe PDF
|
673.11 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
